Prenylcysteine oxidase 1, an emerging player in atherosclerosis
Banfi et al. investigate the role of Prenylcysteine oxidase 1 (PCYOX1), an enzyme implicated in catabolism of prenylated cysteine, in human and murine atherosclerosis. They find that loss of PCYOX1 is anti-atherogenic and understanding its biology and functions can potentially provide significant th...
Guardado en:
Autores principales: | C. Banfi, R. Baetta, S. S. Barbieri, M. Brioschi, A. Guarino, S. Ghilardi, L. Sandrini, S. Eligini, G. Polvani, O. Bergman, P. Eriksson, E. Tremoli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/094301d561fb4a1493a780a94c656a05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An in situ activity assay for lysyl oxidases
por: Huilei Wang, et al.
Publicado: (2021) -
Author Correction: An in situ activity assay for lysyl oxidases
por: Huilei Wang, et al.
Publicado: (2021) -
"Supporting" players take the lead in protecting the overstimulated brain.
por: Liza Gross
Publicado: (2006) -
Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.
por: Christoph Kleinschnitz, et al.
Publicado: (2010) -
Inhibiting LXRα phosphorylation in hematopoietic cells reduces inflammation and attenuates atherosclerosis and obesity in mice
por: Maud Voisin, et al.
Publicado: (2021)